»óÇ°¸í |
NovoMix®
30 FlexPen inj. |
Novolet®
30/70 inj. |
¼ººÐ/
ÇÔ·® |
Insulin aspart 100U/mL
(insulin aspart 30% + protamined insulin aspart 70%)
º¸Á¸Á¦ : m-Å©·¹Á¹(1.72mg), Æä³î(1.5mg) |
Human insulin 100U/mL
(regular insulin 30% + NPH(isophane insulin) 70%)
°áÇÕÁ¦ : Ȳ»êÇÁ·ÎŸ¹Î(0.25mg)
º¸Á¸Á¦ : m-Å©·¹Á¹(1.5mg), Æä³î(0.65mg) |
¾à¸®ÀÛ¿ë
¹×
Ư¡ |
1. blood glucose levelsÀ»
³·Ãß¾î ÀûÀýÇÏ°Ô À¯Áö½ÃÅ´À¸·Î½á Á¤»óÀûÀÎ ´ë»ç°úÁ¤À» ÀÌ·ç°Ô ÇÔ
- ¸»ÃÊ(ƯÈ÷ skeletal muscle°ú fat)¿¡¼ Àν¶¸° ¼ö¿ëü¿¡ °áÇÕÇÏ¿©
glucose uptake¸¦ ÃËÁø
- hepatic glucose productionÀ» ¾ïÁ¦ÇÏ°í glucose¸¦
glucagonÀÇ ÇüÅ·ΠÀúÀå
- lipolysis¿Í proteolysis¸¦ ¾ïÁ¦ÇÏ°í Áö¹æ°ú ´Ü¹éÁú ÇÕ¼º
ÃËÁø
2. A chain(acidic)°ú B chain(basic)µÎ°³ÀÇ ¾Æ¹Ì³ë»ê »ç½½·Î ±¸¼º
Insuline Amino Acids |
Pharmacokinetics of insulins |
Source/ Type |
A chain position |
B chain position |
A8 |
A10 |
A21 |
B28 |
B29 |
B30 |
Onset(hrs) |
Peak(hrs) |
Duration(hrs) |
Human (RI) Aspart Lispro |
Thr Thr Thr |
Ilc Ilc Ilc |
Asn Asn Asn |
Pro Aspartic acid
Lys |
Lys Lys Pro |
Thr Thr Thr |
0.5-1 0.25
0.25 |
1-3
0.5-1.5 |
8-12 3-5 2-5 |
Ala=alanine, Asn=asparagine, Ilc=isoleucine, Lys=lysine,
Pro=proline, Thr=threonine, Val=valine |
*Human insulin B chainÀÇ
28¹ø ¾Æ¹Ì³ë»êÀÎ prolineÀÌ aspartic acid·Î ġȯµÈ ÇüÅÂ
*ÃʼÓÈ¿¼ºÀÎ 30%ÀÇ insulin aspart°¡ regular insulinº¸´Ù ÇÇÇÏÃþ¿¡¼ÀÇ
Èí¼ö°¡ ºü¸£°í 70%ÀÇ ÇÁ·ÎŸ¹Î °áÇÕÇüÀº NPHÀν¶¸°°ú ºñ½ÁÇÑ ÀÛ¿ë½Ã°£À» ³ªÅ¸³¿ |
¼ÓÈ¿¼ºÀÎ 30%ÀÇ regular insulin°ú
Á߽ð£ÇüÀÎ 70%ÀÇ NPH(isophane insuline) À¸·Î ±¸¼º |
*Novomix 30®ÀÇ 30%ÀÇ ÃʼÓÈ¿¼º insulin aspart´Â
¸Å¿ì ºü¸£°Ô ÀÛ¿ëÇÏ¿© »ý¸®ÇÐÀûÀÎ Ç÷´ç ÃÖ°íÁ¡¿¡ µµ´ÞÇÑ ÈÄ ºü¸£°Ô Á¦°ÅµÇ°í 70%ÀÇ Á߽ð£Çü
protamined insulin aspart´Â ¾àÈ¿¸¦ ¿À·¡ Áö¼ÓÇÏ´Â ¿Ï¸¸ÇÑ basal insulin
profileÀ» ³ªÅ¸³¿
¡æ BHI30(biphasic human insulin, novolet 30/70)¿¡ ºñÇØ ½ÄÈÄ
Ç÷´ç Á¶Àý ´É·ÂÀÌ Çâ»óµÇ°í HypoglycemiaÀÇ risk¸¦ ÁÙÀÓ |
¾àµ¿ÇÐ |
Onset |
10~20min |
30min |
Max. effect |
1~4hrs |
2~8hrs |
Duration |
24hrs |
24hrs |
ÀûÀÀÁõ |
Àν¶¸°
¿ä¹ýÀ» ÇÊ¿ä·Î ÇÏ´Â ´ç´¢º´ |
¿ë¹ý.¿ë·® |
ÀϹÝÀûÀÎ
insulin ¿ä±¸·® : 0.5~1.0U/kg/day, ȯÀÚÀÇ Ç÷´ç º¯È¿¡ µû¶ó °áÁ¤ |
ÀϹÝÀûÀ¸·Î ½ÄÀü 5~10ºÐ Åõ¿©, ½Ä»ç
Á÷Èĵµ °¡´É
(¡ñ biphasic human insulinº¸´Ù ÀÛ¿ë ¹ßÇö ½Ã°£ÀÌ ºü¸§) |
ID : 1ȸ 4~20U¸¦ ¾Æħ ½Ä»ç Àü 30ºÐ
À̳»¿¡ SC
MD : 4~100U/day ÇÊ¿ä½Ã ¿ë·® ÃÊ°ú °¡´É |
ºÎÀÛ¿ë |
ÀúÇ÷´ç,
°ú¹ÎÁõ, ½Å°æÅë, °£ ±â´É ÀÌ»ó µî ÀϹÝÀû Àν¶¸° ºÎÀÛ¿ë¿¡ ÁØÇÔ |
ÀúÀå¹æ¹ý |
¹ÐºÀ¿ë±â,
µ¿°áÀ» ÇÇÇÏ¿© ³Ã¼Ò(2¡É-8¡É)º¸°ü, »ç¿ë ÁßÀÎ Àν¶¸°Àº »ó¿Â¿¡¼ 1°³¿ù°£ ¾ÈÁ¤ |
»ç¿ë±â°£ |
30°³¿ù |
18°³¿ù |
Category |
C |
B |
º¸Çè¾à°¡ |
11,706¿ø/3mL/pen |
8,004¿ø/3mL/pen |
1ÀϾడ |
1,170¿ø~2,340¿ø/day |
800¿ø~1,600¿ø/day |